Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2012
02/21/2012CA2551627C Primers and a screening method for identification of artemisinin producing plants
02/21/2012CA2482097C Methods for isolating nucleic acids
02/21/2012CA2321934C Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
02/21/2012CA2296841C Tropoelastin derivatives
02/21/2012CA2264592C Bioconjugates and delivery of bioactive agents
02/21/2012CA2158936C Compositions and methods for utilizing conditionally lethal genes
02/16/2012WO2012021106A1 Detection of dengue virus serotypes 1 to 4
02/16/2012WO2011121456A3 Nucleic acids and protein sequences of costunolide synthase
02/16/2012WO2011109113A9 Uses of beta-nicotinamide adenine dinucleotide
02/16/2012WO2011102913A3 Wicking-based reagent-solution draining in an automated system
02/16/2012WO2010107740A8 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
02/16/2012US20120042421 Perilla-derived promoter functioning in petals
02/16/2012US20120042414 Chimeric promoters and methods of use
02/16/2012US20120042410 Abscisic acid carrier gene and transgenic plant expressing the same
02/16/2012US20120042407 Corn event 5307
02/16/2012US20120041184 RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
02/16/2012US20120041175 Novel autography regulators atg14l and rubicon
02/16/2012US20120041057 SYNTHESIS AND CHARACTERIZATION OF C8 ANALOGS OF c-di-GMP
02/16/2012US20120041056 Nucleic acids specifically binding with human factor vii/viia and uses thereof
02/16/2012US20120041055 Composite polynucleic acid therapeutics
02/16/2012US20120041054 Compositions and methods for the treatment of sepsis and other disorders involving phospholipase a2 induction
02/16/2012US20120041052 Compositions and Methods to Treat Muscular & Cardiovascular Disorders
02/16/2012US20120041051 Compositions And Methods For Inhibiting Expression Of MIG-12 Gene
02/16/2012US20120041050 Antisense oligonucleotides for inducing exon skipping and methods of use thereof
02/16/2012US20120041049 Design of small-interfering rna
02/16/2012US20120041048 COMPOSITIONS AND METHODS RELATING TO miR-31
02/16/2012US20120040917 Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease
02/16/2012US20120040906 Protein targets in disease
02/16/2012US20120040905 Means for purifying a coagulation protein, and methods for implementing same
02/16/2012US20120040891 Hiv fusion inhibitor peptides with improved biological properties
02/16/2012US20120040884 Methods and Reagents for Treatment and Diagnosis of Vascular Disorders and Age-Related Macular Degeneration
02/16/2012US20120040865 Target substance detection method using aptamer
02/16/2012US20120040862 Method for detecting and quantifying endogenous wheat dna sequence
02/16/2012US20120040857 Isolation of factors that associate directly or indirectly with chromatin
02/16/2012US20120040854 Method for in vitro diagnosis or prognosis of testicular cancer
02/16/2012US20120040851 miRNA TARGETS
02/16/2012US20120040451 Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
02/16/2012US20120040431 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites
02/16/2012US20120040412 Amylases, nucleic acids encoding them and methods for making and using them
02/16/2012US20120040410 Thermohemicellulases for lignocellulosic degradation
02/16/2012US20120040403 Diguanylate cyclase method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof
02/16/2012US20120040402 Plasmid system for multigene expression
02/16/2012US20120040398 Engineered cleavage half-domains
02/16/2012US20120040397 Photo-Crosslinked Nucleic Acid Hydrogels
02/16/2012US20120040377 Recognition of cyp2e1 epitopes
02/16/2012US20120040375 Anti-muc1 antibody
02/16/2012US20120040366 Compositions, methods and uses for disease diagnosis
02/16/2012US20120040363 Method for enriching a prokaryotic dna
02/16/2012US20120040360 Compositions, methods and kits to detect dicer gene mutations
02/16/2012US20120040357 Compositions, methods and kits to detect dicer gene mutations
02/16/2012US20120040353 Detection and quantification of microRNAs in the circulation and the use of circulating microRNAs as biomarkers in cancer
02/16/2012US20120040352 Primers, probes and methods for nucleic acid amplification
02/16/2012US20120040347 Polymorphism in CYP3A4 Gene Affecting Drug Metabolizing and Uses Thereof
02/16/2012US20120040341 Method for the Detection and Diagnosis of Cancer Involving Primers and Probes for the Specific Detection of the MAGE-A3-Marker
02/16/2012US20120039993 Detection of Gene Expression
02/16/2012US20120039988 Cancer-targeting peptides and uses thereof in cancer therapy
02/16/2012US20120039986 Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
02/16/2012US20120039925 Tuberculosis tb vaccine to prevent reactivation
02/16/2012US20120039924 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
02/16/2012US20120039921 Poultry viral materials and methods related thereto
02/16/2012US20120039919 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods
02/16/2012US20120039915 Glioblastoma multiforme-reactive antibodies and methods of use thereof
02/16/2012US20120039912 Rspondin-3 inhibition in bone disorders
02/16/2012US20120039911 Cd93 or use of soluble fragment thereof
02/16/2012US20120039905 The Role of p110 delta Signaling in Morbidity and Lung Pathology Induced by Influenza Virus Infection
02/16/2012US20120039893 Mutant smoothened and methods of using the same
02/16/2012US20120039892 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
02/16/2012US20120039890 Methods of treatment using antibodies to neutrokine-alpha
02/16/2012US20120039889 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion
02/16/2012US20120039887 Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
02/16/2012US20120039880 FRAGMENTATION RESISTANT IgG1 Fc-CONJUGATES
02/16/2012US20120039877 E1-minus adenoviruses and use thereof
02/16/2012US20120039875 Diagnostic and therapeutic methods and compositions involving pten and breast cancer
02/16/2012US20120039870 Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
02/16/2012US20120039861 Identification of extracellular form of pten that can be used to treat tumors
02/16/2012US20120039858 Methods and compositions for inhibiting propagation of viruses using recombinant tetherin constructs
02/16/2012US20120039842 Compositions and methods that enhance an immune response
02/16/2012US20120039810 Aptamer-containing compositions and methods for targeting e-selectin
02/16/2012US20120039808 Brain Tumor Stem Cell Differentiation Promoter, and Therapeutic Agent for Brain Tumor
02/16/2012CA2810856A1 Compositions and methods for quantifying a nucleic acid sequence in a sample
02/16/2012CA2804424A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
02/16/2012CA2804416A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
02/15/2012EP2418281A2 Methods and compositions for delivering polynucleotides
02/15/2012EP2418274A2 Multimeric Oxidoreductases
02/15/2012EP2418212A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma
02/15/2012EP2417249A1 Dna-cell conjugates
02/15/2012EP2417147A2 Multiplexed sites for polymer synthesis
02/15/2012EP1636268B1 Humanized antibodies that recognize beta amyloid peptide
02/15/2012EP1532446B1 G-protein coupled receptor ligands and methods
02/15/2012EP1532161B1 Vectors for expression of hml-2 polypeptides
02/15/2012CN102356158A Methods of modulating the sex of avians
02/15/2012CN102351932A Structure, preparation method and purpose of anti-influenza virus oligonucleotide
02/15/2012CN101805730B 花生健康组织和病组织简便快速dna提取方法 Dna extraction method is simple, rapid healthy tissue and diseased tissues peanuts
02/14/2012US8115054 Maize with enhanced tolerance to fungal pathogen
02/14/2012US8114985 Anti-MicroRNA oligonucleotide molecules
02/14/2012US8114984 RNAi modulation of Aha and therapeutic uses thereof
02/14/2012US8114983 Compositions and use of EPAS1 inhibitors
02/14/2012US8114982 Multi-microRNA methods and compositions
02/14/2012US8114981 Method and medicament for inhibiting the expression of a given gene
02/14/2012US8114980 Transforming caenorhabditis and using as animal model for gene expression inhibition; RNA interference
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 899